장희준 (서울대학교병원운영 서울특별시 보라매병원)님 | 한빛사연구자 > 한빛사

서울대학교병원운영 서울특별시 보라매병원

최종업데이트 2022.02.24.

Multicenter Prospective Cohort Study on Clinical Outcomes and Fibrosis Patterns in Biopsy-Proven Steatotic Liver Disease Subtypes
- Gastroenterology, Jan 29 2026, S0016-5085(26)00030-2 | https://doi.org/10.1053/j.gastro.2026.01.007
- 2026-01
- 의약학
- 한빛사논문
Outcomes of Oral Antidiabetic Drugs in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Nationwide Target Trial Emulation Study
- Clin. Mol. Hepatol., Jan 06 2026, | https://doi.org/10.3350/cmh.2025.1006
- 2026-01
- 한빛사논문
Outcomes of Various Classes of Oral Antidiabetic Drugs on Nonalcoholic Fatty Liver Disease
- JAMA Intern. Med., Feb 12 2024, e238029 | https://doi.org/10.1001/jamainternmed.2023.8029
- 2024-02
- 의약학
- 한빛사논문
Aspirin Use and Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B With or Without Cirrhosis
- Hepatology, First published: 31 January 2022 | https://doi.org/10.1002/hep.32380
- 2022-01
- 의약학
- 한빛사논문
Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients with Chronic Hepatitis B
- Clin. Gastroenterol. Hepatol., Available online 6 September 2021 | https://doi.org/10.1016/j.cgh.2021.09.001
- 2021-09
- 의약학
- 한빛사논문

연구자 ID

저자논문